Oral Doxifluridine in Advanced Hepatocellular Carcinoma: A Phase II Study

Publisher： Karger

E-ISSN： 1423-0232|59|3|204-209

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.3, 2000-10, pp. : 204-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

By  

Oncology, Vol. 85, Iss. 1, 2013-07 ,pp. : 44-52

Karger

Access to resources Recommend Favorite

Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 154-158

Karger

Access to resources Recommend Favorite

Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2011-11 ,pp. : 281-290

Karger

Access to resources Recommend Favorite

Preoperative Chemoradiation in Locally Advanced Pancreatic Carcinoma: A Phase II Study

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 436-442

Karger

Access to resources Recommend Favorite

A phase II trial of second‐line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1620-1627

John Wiley & Sons Inc

Access to resources Recommend Favorite